Compare AG & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AG | GMED |
|---|---|---|
| Founded | 1979 | 2003 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 12.9B |
| IPO Year | 2004 | 2012 |
| Metric | AG | GMED |
|---|---|---|
| Price | $22.54 | $84.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 14 |
| Target Price | $21.92 | ★ $100.42 |
| AVG Volume (30 Days) | ★ 18.8M | 963.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.09% | N/A |
| EPS Growth | N/A | ★ 422.67 |
| EPS | N/A | ★ 3.92 |
| Revenue | N/A | ★ $2,938,931,000.00 |
| Revenue This Year | $13.75 | $10.72 |
| Revenue Next Year | $26.43 | $6.45 |
| P/E Ratio | $143.01 | ★ $21.57 |
| Revenue Growth | N/A | ★ 16.65 |
| 52 Week Low | $5.19 | $51.79 |
| 52 Week High | $32.00 | $101.40 |
| Indicator | AG | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 40.64 | 36.37 |
| Support Level | $20.21 | $57.74 |
| Resistance Level | $27.90 | $87.16 |
| Average True Range (ATR) | 1.64 | 2.78 |
| MACD | -0.82 | -0.89 |
| Stochastic Oscillator | 0.96 | 2.80 |
First Majestic Silver Corp is engaged in the production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. It owns three producing mines in Mexico consisting of the San Dimas Silver/Gold Mine, the Santa Elena Silver/Gold Mine, and the La Encantada Silver Mine.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.